Moffitt at AACR
Every year the American Association for Cancer Research (AACR) bring scientists, clinicians and other health care professionals together to share the latest advances in cancer science and medicine. This year Moffitt is proud to once again bring our latest science to the annual meeting. Our scientists and clinicians will be sharing advancements in the areas of evolutionary therapy, targeted therapies, healthcare disparities and more for several cancer types. For a complete list of Moffitt abstracts check out our Virtual Program.
Interested in talking to us one on one? Stop by our booth #3213 and learn more about the impact Moffitt is making in cancer research. Recruiters will also be on site if you’re interested in learning more about our postdoctoral training.
Features from 2022
Do Younger Colorectal Cancer Patients Have Worse Outcomes?
Researchers aim to compare the treatment outcomes and adverse events among different age groups of patients with mCRC.
New Non-Small Cell Lung Cancer Biomarkers Found
Distinct ecologies exist between disease that does and does not progress.
Is Adaptive Therapy in Prostate Cancer Patients a Promising Treatment?
Results of Moffitt-initiated phase 2a clinical trial suggest it can prolong cancer progression
Neoadjuvant Therapy Proves Effective in Muscle Invasive Bladder Cancer
This trial aimed to find an alternative option to surgery that helped patients keep their bladders while preventing cancers from coming back.
Black and Latino Cancer Patients with COVID-19 Faced More Treatment Delays During Pandemic
Moffitt study shows racial and ethnic disparities among cancer patients who contracted the virus.
What is the Link Between HPV and Oropharyngeal Cancer?
Moffitt researchers want to learn why some men present with an oral HPV that clears on its own while others do not.
Imaging May Help Guide Ovarian Cancer Treatment Decisions
Moffitt study finds radiomic feature that may predict best first-line treatment approach for these patients.
Sexual, Gender Minority Patients Report More Concerns Starting Cancer Treatment
Psychosocial issues, low quality of life could be addressed with early interventions, Moffitt study shows
Media Contact:
For additional information on Moffitt’s research presented at AACR please reach out to:
Kim Polacek, APR, CPRC
Senior PR Account Coordinator
Email
2022 Video Features
Moffitt 2022 AACR Video Playlist
Moffitt Resources
Office of Innovation and Industry Alliances
Forging partnerships with startups and industry to bring cutting edge ideas and discovers to the marketplace.
Science & Research Careers
Our researchers drive cutting-edge discoveries that are rapidly translated into improved diagnostic, preventive and therapeutic advances.
Diversity, Equity and Inclusion
The diversity of our employees and communities is valued and supported as essential components to contributing to the prevention and cure of cancer.
Clinical Trials
With our robust portfolio of clinical trials, Moffitt remains firmly established at the forefront of cancer research.
Training & Education
We provide numerous education opportunities for physicians and other healthcare professionals, international scholars, postdoctoral, graduate and undergraduate students
Physician Liaison Team
Our goal is to forge partnerships with healthcare professionals to improve patient access and outcomes.
